Skip to main content
. Author manuscript; available in PMC: 2009 Jun 8.
Published in final edited form as: J Am Geriatr Soc. 2008 Jul;56(7):1361–1363. doi: 10.1111/j.1532-5415.2008.01722.x

Table 1.

Characteristics and Outcomes of Residents with Dementia According to Unit Type

Variable All Unit
Types(n = 134)
Dementia-Specific
Care Unit (n = 24)
Non–Dementia-Specific
Care Unit (n = 110)
Difference in Mean
(95% Confidence Interval)*
Demographic characteristics
  Age, mean ± SD 86.1 ± 6.7 85.7 ± 6.5 86.2 ± 6.8 −0.5 (−3.5–2.6)
  Female, % 80.6 75.0 81.8
  White, % 79.9 95.8 76.4*
  Education, years 13.5 ± 3.0 14.7 ± 2.8 13.2 ± 3.0* 1.5 (0.2–2.8)
  AL tenure, years 0.3 ± 1.0 0.1 ± 0.9 0.4 ± 1.0 −0.3 (−0.7–0.15)
  AL monthly charges, dollars 3,139.5 ± 1,463.6 5,133.5 ± 1,617.5 2,706.9 ± 1,001.7* 2,426.6 (1,704.7–3,148.5)
Clinical characteristics, mean ± SD
  Mini-Mental State Examination score 14.6 ± 7.7 11.7 ± 6.8 15.3 ± 7.7* −3.6 (−7.0 to −2.0
  Psychogeriatric Dependency Rating Scale—Physical 14.2 ± 8.8 16.7 ± 8.7 13.7 ± 8.8 3.0 (0.9–6.9)
  General Medical Health Rating 2.7 ± 0.8 2.9 ± 0.9 2.7 ± 0.8 −0.2 (−0.2–0.5)
  Caregiver Activity Survey, 4.5 ± 1.9 4.9 ± 1.3 4.4 ± 2.0 0.5 (−0.1–1.2)
  NPI total 2.0 ± 1.2 2.4 ± 1.1 2.0 ± 1.2 0.5 (0.2–1.1)
  Specific NPI domain, %
    Delusions 35.1 41.7 33.6
    Hallucinations 11.2 20.8 9.1
    Agitation or aggression 36.6 50.0 33.6
    Depression or dysphoria 26.9 25.0 27.3
    Anxiety 22.4 37.5 19.1*
    Euphoria 4.5 4.2 4.6
    Apathy 23.9 16.7 25.5
    Disinhibition 11.2 16.7 10.0
    Irritability 32.1 45.8 29.1
    Aberrant motor behavior 21.1 37.5 17.4*
    Sleep 27.1 20.8 28.4
    Appetite or eating disorders 12.8 16.7 11.9
Dementia care indicators
  Complete dementia examination, % 73.0 82.6 70.9
  Complete dementia treatment, % 52.2 54.2 51.8
  Acetylcholinesterase inhibitor use 30.6 50.0 26.4*
  Psychotropic drug use§ 53.0 54.2 52.7
Group activities 69.4 ± 62.6 95.6 ± 76.9 63.6 ± 57.8* 46.3 (13.6–79.0)
Television watching# 61.2 ± 69.9 36.3 ± 58.8 66.7 ± 71.2 −30.4 (−61.2–0.5)
Outcomes**
  Alzheimer’s Disease–Related Quality of Life score, mean ± SD 77.8 ± 13.6 75.5 ± 15.7 78.3 ± 13.1 −2.8 (−9.8–4.2)
  Caregiver burden (range 1–5)†† 2.5 ± 1.2 2.4 ± 1.5 2.5 ± 1.2 −0.1 (−0.6–0.5)
  Survival time, days‡‡ 524.3 ± 406.5 496.1 ± 316.3 530.5 ± 424.6

Note: Independent-samples t-tests (two-tailed) were calculated to determine statistical significance for continuous variables. Pearson chi-square tests and Fisher exact tests, in cases in which contingency table cell counts were small, were used for discrete variables. Log-rank chi-square tests were used for survival time

*

P <.05.

Values have been log-transformed because of positively skewed distributions.

Estimates the number of minutes per day required for daily care.

§

Any routine use of antidepressants, mood stabilizers, neuroleptics, benzodiazepines, hypnotics, opiates, or anxiolytics.

Approximate number of hours participants spent in group activities (e.g., social hour, exercise class, bus trips) per month.

#

Approximate number of hours participants spent watching television per month.

**

Includes cross-sectional and longitudinal outcomes.

††

Perceived burden of caring for a particular resident on a daily basis.

‡‡

Median follow-up time of 437 days. Date of discharge could not be ascertained for 12 participants who died in a nursing home unit (n = 4), or at a medical hospital (n = 8). For these cases, date of discharge to more-intensive care level was approximated as the midpoint between dates of last known time residing in assisted living (AL) and death. In another four cases with unknown discharge dates, death occurred in an unknown location (n = 3) or at another AL (n = 1).

SD = standard deviation; NPI = Neuropsychiatric Inventory.